Measurement of nitric oxide and 8-isoprostane in exhaled breath of children with atopic eczema

Clinical and Experimental Dermatology

Volumn 34, Issue 5, 2009, Pages 607-612

  Zinelli, C ^a   Caffarelli, C ^a   Strid, J ^b   Jaffe, A ^c   Atherton, D J ^c  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; BIOLOGICAL MARKER; NITRIC OXIDE;

ADOLESCENT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED STUDY; COUGHING; DISEASE MARKER; DISEASE SEVERITY; EXHALATION; FEMALE; FORCED EXPIRATION; FORCED EXPIRATORY VOLUME; HAY FEVER; HUMAN; LUNG FUNCTION; MALE; PEAK EXPIRATORY FLOW; PREDICTIVE VALIDITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; RHINITIS; SCHOOL CHILD; WHEEZING;

ADOLESCENT; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CHILD; DERMATITIS, ATOPIC; DINOPROST; FEMALE; HUMANS; MALE; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; PULMONARY VENTILATION;

EID: 66449093375     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.03142.x     Document Type: Article

References (25)

1. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis: a prospective follow-up to 7 years of age. Allergy 2000 55 : 240 5.
2. Pohunek P, Warner JO, Turzikova J et al. Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma. Pediatr Allergy Immunol 2005 16 : 43 51. (Pubitemid 40313963)
3. Morrow JD. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical catalyzed mechanism. Proc Natl Acad Sci USA 1990 87 : 9383 7.
4. Praticò D, Lawson JA, Rokach J et al. The isoprostanes in biology and medicine. Trends Endocrinol Metab 2001 12 : 243 7.
5. Montuschi P, Corradi M, Ciabattoni G et al. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma. Am J Respir Crit Care Med 1999 160 : 216 20.
6. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary diseases. Am J Respir Crit Care Med 2001 163 : 1693 722.
7. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 2006 130 : 1541 6.
8. Profita M, La Grutta S, Carpagnano E et al. Noninvasive methods for the detection of upper and lower airway inflammation in atopic children. J Allergy Clin Immunol 2006 118 : 1068 74.
9. Dinakar C, Craff M, Laskowski D. Infants and toddlers without asthma with eczema have elevated exhaled nitric oxide levels. J Allergy Clin Immunol 2006 117 : 212 13.
10. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol (Stockh) Supplement 1980 92 : 44 7.
11. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000 162 : 1403 6.
12. Reitamo S, Wollenberg A, Schopf E et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000 136 : 999 1006.
13. The International Study of Asthma and Allergies in Childhood (ISAAC). Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. ISAAC Lancet 1998 351 : 1225 32.
14. American Thoracic Society. Standardization of spirometry. 1994 Update. Am J Respir Crit Care Med 1995 152 : 1107 36.
15. ATS/ERS. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide 2005. Am J Respir Crit Care Med 2005 171 : 912 30.
16. Kharitonov SA, Gonio F, Kelly C et al. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 2003 21 : 433 8.
17. Montuschi P, Barnes PJ. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 2002 23 : 232 7.
18. Baraldi E, Ghiro L, Piovan V et al. Increased exhaled 8-isoprostane in childhood asthma. Chest 2003 124 : 25 31. (Pubitemid 36851327)
19. Shahid SK, Kharitonov SA, Wilson NM et al. Exhaled 8-isoprostane in childhood asthma. Respir Res 2005 6 : 79.
20. Van Hoydonck PGA, Wuyts WA, Vanaudenaerde BM et al. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. Eur Respir J 2004 23 : 189 92.
21. Meyts I, Proesmans M, Van Gerven V et al. Tidal off-line exhaled nitric oxide measurements in a pre-school population. Eur J Pediatr 2003 162 : 506 10.
22. Taniuchi S, Kojima T, Hara Mt K et al. Increased serum nitrate levels in infants with atopic dermatitis. Allergy 2001 56 : 693 5.
23. Kellogg DL Jr., Zhao JL, Coey U, Green JV. Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol 2005 98 : 629 32.
24. Goldsmith PC, Leslie TA, Hayes NA et al. Inhibitors of nitric oxide synthase in human skin. J Invest Dermatol 1996 106 : 113 8.
25. Griffith OW, Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol 1995 57 : 707 36.